| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390910 Antitumor, anticancer agents; for drug resistant tumors, cancers |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390892 nucleotide sequences and genes that code for proteins as well as antibodies raised against such proteins; enzymes used in screening assays to identify antiprotozoa agents; antibodies use to protect animals from disease caused by parasites |
| 06/24/2008 | US7390891 Affect aging and/or proliferation of cells in the human |
| 06/24/2008 | US7390888 Dendritic cell potentiation |
| 06/24/2008 | US7390887 Antibodies against PRO4330 |
| 06/24/2008 | US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390878 PRO6090 polypeptides |
| 06/24/2008 | US7390877 Vectors with DNA encoding pro polypeptides |
| 06/24/2008 | US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390874 Peptide, method of production thereof, and pharmaceutical composition containing the same |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390872 fusion proteins has high transduction potential, inhibits the NF- kappa B pathway; biodrugs as antiinflammatory agents, viricides, antiproliferative agents, immunostimulants |
| 06/24/2008 | US7390871 Isolated polypeptide as antitumor agents, anticarcinogenic agents; amino acid sequences binding to major histocompatibility complex (MHC); tumor antigen induces killer T cells against cancer; anti-cancer vaccines, biodrugs |
| 06/24/2008 | US7390870 Immune-enhancing peptides |
| 06/24/2008 | US7390834 Increased or improved bioavailability of the active agents for oral, intracolonic, pulmonary, and other routes of administrations |
| 06/24/2008 | US7390801 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/24/2008 | US7390789 Thio-containing inhibitors of aminopeptidase P, and compositions thereof |
| 06/24/2008 | US7390788 Pharmaceutically active peptide T composition comprising non-aggregated D-ala1-Peptide T-amide, produced by suspending the D-ala1-Peptide T-amide in 80% trifluoroethanol for 24 hours at 37 C with shaking, removing trifluoroethanol, and suspending the D-ala1-Peptide T-amide in aqueous solution |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390786 Protein formulations with reduced viscosity and uses thereof |
| 06/24/2008 | US7390785 Amino acid sequences; from venom of snails; analgesics |
| 06/24/2008 | US7390784 Binary complexes formed have an enlarged target binding surface area and thus exhibit increased affinity, specificity or selectivity as compared to free drug forms |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390782 Methods and products related to metabolic interactions in disease |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390658 Lymphoid dendritic cells generated from hematopoietic stem cells which encode viricidal and antitumor agents for preventing tumor metastasis and viral infection; immunotherapy |
| 06/24/2008 | US7390657 Method for generating primate trophoblasts |
| 06/24/2008 | US7390638 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases |
| 06/24/2008 | US7390637 Keratinocyte derived interferon |
| 06/24/2008 | US7390635 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390632 Soluble ErbB3 receptor isoforms |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390509 Compositions and methods for nutrition supplementation |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390496 Therapeutic treatments for repetitive hand washing |
| 06/24/2008 | US7390492 Producing a passive immunity vaccine against Sarcocystis neurona by providing Sarcocystis neurona 16 kDa and 30 kDa antigens as determined by SDS polyacrylamide gel electrophoresis;immunizing mammal in mixture with adjuvant; removing serum; isolating antibodies; administering antibodies |
| 06/24/2008 | US7390491 Agents comprising midkine or an inhibitor thereof as active ingredient |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/24/2008 | US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/24/2008 | US7390482 Drug for auditory dysfunction |
| 06/24/2008 | US7390481 Mammalian cytokine complexes |
| 06/19/2008 | WO2008074035A1 Hcv protease inhibitors and uses thereof |
| 06/19/2008 | WO2008073660A1 Molecules and methods for treatment and detection of cancer |
| 06/19/2008 | WO2008073653A2 Il- 17b for use in wound healing |
| 06/19/2008 | WO2008073642A2 Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| 06/19/2008 | WO2008073631A2 Composition for cartilage |
| 06/19/2008 | WO2008073615A2 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 06/19/2008 | WO2008073603A2 Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| 06/19/2008 | WO2008073466A2 Alpha b-crystallin as a therapy for inflammation |
| 06/19/2008 | WO2008073463A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | WO2008073441A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 06/19/2008 | WO2008073395A2 Compositions and methods for cardiac tissue protection and regeneration |
| 06/19/2008 | WO2008073392A2 Compositions and methods for cardiac tissue protection and regeneration |
| 06/19/2008 | WO2008073351A2 Uses of cerberus, coco and derivatives thereof |
| 06/19/2008 | WO2008073312A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 06/19/2008 | WO2008073294A2 Inhibition of angiogenesis and tumor growth by inhibitors of beta ii or delta protein kinase c |
| 06/19/2008 | WO2008073292A2 Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn) |
| 06/19/2008 | WO2008073230A1 Liposome containing cardiolipin for improvement of mitochondrial function |
| 06/19/2008 | WO2008073174A2 Antimicrobial therapy |
| 06/19/2008 | WO2008073162A2 Lysine acetylation sites |
| 06/19/2008 | WO2008072781A1 Method for prevention or treatment of memory disorder in mammal |
| 06/19/2008 | WO2008071984A1 Administration of the gonadotropin-releasing hormone antagonist teverelix |
| 06/19/2008 | WO2008071972A1 Novel compounds and their effects on feeding behaviour |
| 06/19/2008 | WO2008071934A1 Treatment of cachexia |
| 06/19/2008 | WO2008071755A2 Casein-derived peptides having anxiolytic activity |
| 06/19/2008 | WO2008071738A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/19/2008 | WO2008071438A2 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor |
| 06/19/2008 | WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 06/19/2008 | WO2008071010A1 Combination treatments with selected growth/hormone regulatory factors for diabetes and related diseases |
| 06/19/2008 | WO2008070992A1 Trpv1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 06/19/2008 | WO2008070902A1 Tgf-beta compositions for treating infertility |
| 06/19/2008 | WO2008070893A1 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system |
| 06/19/2008 | WO2008070892A1 Promoting production of extracellular matrix by fibroblast cells and/or promoting migration of fibroblast cells |
| 06/19/2008 | WO2008054792A9 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases |
| 06/19/2008 | WO2008051514A3 Hcv ns3 protease inhibitors |
| 06/19/2008 | WO2008050133A3 Inhibition of beta-amyloid aggregation |
| 06/19/2008 | WO2008049974A8 Peptide vaccine for influenza virus |
| 06/19/2008 | WO2008049058A3 Cln2 treatment of alzheimer's disease |
| 06/19/2008 | WO2008049043A3 Ophthalmic compositions comprising diglycine |
| 06/19/2008 | WO2008048430A3 Identification, quantification and conversion of succinimide in proteins |
| 06/19/2008 | WO2008043570A8 Interferon type i supporting compounds |
| 06/19/2008 | WO2008043424A3 Composition to treat or prevent gastrointestinal infection |
| 06/19/2008 | WO2008039351A3 Method of manufacturing tablets containing pharmacologically active agents |
| 06/19/2008 | WO2008028965A3 Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof |
| 06/19/2008 | WO2008027807A3 Control of diabetes and obesity |
| 06/19/2008 | WO2008011006A3 Methods for treating pain and screening analgesic compounds |
| 06/19/2008 | WO2008005531A3 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 06/19/2008 | WO2007139846A3 Bacterial expression of phosphorylated hsp20 and reagents therefor |
| 06/19/2008 | WO2007111866A3 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |